Corporate Banner
Satellite Banner
Technology Networks Header
Friday, July 25, 2014
Technology Networks
 
Register | Sign in
Home Page>News

  News Archive

QIAGEN Licences Biomarker for Blood Disorder from CeMM Vienna
Thursday, April 10, 2014
Company plans to develop a molecular diagnostic test for the calreticulin mutations.

Merck Millipore, VWR Extend Western European Distribution Agreement
Wednesday, April 09, 2014
Provides VWR access to more Merck Millipore products and reagents for chemical and microbiological analysis.

ProteoMediX Raises CHF 3.2M (€2.6M) in Financing
Wednesday, April 09, 2014
The Company has announced the successful closing of a Series B equity financing round from existing and new investors.

Faster Visa Endorsement will Support International Mobility for Top Researchers
Monday, April 07, 2014
This visa route is designed for the brightest and best bringing them from outside the European Economic Area to the UK.

Sony DADC to Enter Into a Manufacturing Agreement with Trinean
Friday, April 04, 2014
Sony DADC to supply microfluidic disposables for Trinean’s high throughput DropSense96™ spectrometers and its Xpose™ Touch & Go sample QC analyzer.

EMD Serono, Pfizer and Broad Institute Enter Research Agreement
Friday, April 04, 2014
Agreement aims to identify biomarkers relevant to future therapies in the area of Systemic Lupus Erythematosus and Lupus Nephritis.

AMSBIO Publishes Comprehensive Cell Culture Handbook
Friday, April 04, 2014
Extensive 48-page handbook is intended for research scientists looking to culture cells in more physiologically relevant environments.

AstraZeneca, MRC Collaboration to Create New Centre for Early Drug Discovery
Monday, March 31, 2014
The Companies today announced the groundbreaking collaboration aimed at better understanding the mechanisms of human disease. The collaboration will see the creation of a joint research facility at AstraZeneca’s new R&D centre in Cambridge in the UK.

Drug Developers Drawn to Orphan Drugs Market
Thursday, March 27, 2014
Breakthrough therapies for rare diseases command premium pricing, particularly if no alternatives exist.

<< 6 7 8 9 10 11 12 >>
Showing Results 81 - 90 of 3431

Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv